State Street’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.2M Buy
1,333,858
+61,123
+5% +$662K ﹤0.01% 2386
2025
Q4
$16.3M Buy
1,272,735
+315,844
+33% +$3.9M ﹤0.01% 2368
2025
Q3
$10.7M Buy
956,891
+3,662
+0.4% +$35.3K ﹤0.01% 2602
2025
Q2
$9.46M Buy
953,229
+113,671
+14% +$1.11M ﹤0.01% 2632
2025
Q1
$7.88M Buy
839,558
+6,035
+0.7% +$63.4K ﹤0.01% 2672
2024
Q4
$7.64M Buy
833,523
+23,151
+3% +$170K ﹤0.01% 2769
2024
Q3
$6.3M Buy
810,372
+21,218
+3% +$153K ﹤0.01% 2849
2024
Q2
$4.77M Sell
789,154
-228,777
-22% -$1.41M ﹤0.01% 2952
2024
Q1
$5.98M Buy
1,017,931
+8,624
+0.9% +$51.2K ﹤0.01% 2854
2023
Q4
$7.91M Sell
1,009,307
-256,028
-20% -$1.78M ﹤0.01% 2721
2023
Q3
$9.25M Sell
1,265,335
-525,238
-29% -$4.37M ﹤0.01% 2640
2023
Q2
$18.7M Sell
1,790,573
-283,983
-14% -$2.73M ﹤0.01% 2280
2023
Q1
$21.5M Buy
2,074,556
+64,844
+3% +$830K ﹤0.01% 2173
2022
Q4
$27.7M Buy
2,009,712
+504,149
+33% +$7.01M ﹤0.01% 2013
2022
Q3
$30.8M Sell
1,505,563
-80,331
-5% -$1.76M ﹤0.01% 1928
2022
Q2
$30.7M Sell
1,585,894
-17,044
-1% -$349K ﹤0.01% 1950
2022
Q1
$34.5M Sell
1,602,938
-92,978
-5% -$2.11M ﹤0.01% 1997
2021
Q4
$46.8M Sell
1,695,916
-215,098
-11% -$5.94M ﹤0.01% 1851
2021
Q3
$49.6M Buy
1,911,014
+27,320
+1% +$731K ﹤0.01% 1811
2021
Q2
$51.1M Sell
1,883,694
-181,983
-9% -$4.44M ﹤0.01% 1830
2021
Q1
$48.3M Buy
2,065,677
+131,791
+7% +$2.66M ﹤0.01% 1771
2020
Q4
$29.6M Buy
1,933,886
+96,287
+5% +$1.22M ﹤0.01% 1987
2020
Q3
$22.2M Sell
1,837,599
-35,681
-2% -$339K ﹤0.01% 1983
2020
Q2
$19.1M Buy
1,873,280
+156,423
+9% +$1.61M ﹤0.01% 2057
2020
Q1
$17.9M Buy
1,716,857
+188,263
+12% +$2.36M ﹤0.01% 1905
2019
Q4
$24.5M Buy
1,528,594
+138,848
+10% +$2.12M ﹤0.01% 2001
2019
Q3
$25.6M Sell
1,389,746
-11,956
-0.9% -$234K ﹤0.01% 1899
2019
Q2
$27.6M Buy
1,401,702
+71,828
+5% +$1.46M ﹤0.01% 1891
2019
Q1
$30.4M Buy
1,329,874
+36,908
+3% +$801K ﹤0.01% 1770
2018
Q4
$26M Sell
1,292,966
-64,692
-5% -$1.34M ﹤0.01% 1799
2018
Q3
$29.5M Buy
1,357,658
+169,233
+14% +$3.76M ﹤0.01% 1907
2018
Q2
$26.4M Buy
1,188,425
+70,846
+6% +$1.45M ﹤0.01% 1937
2018
Q1
$19.3M Buy
1,117,579
+147,487
+15% +$2.46M ﹤0.01% 2080
2017
Q4
$16.1M Buy
970,092
+56,787
+6% +$969K ﹤0.01% 2198
2017
Q3
$15.6M Buy
913,305
+35,448
+4% +$595K ﹤0.01% 2183
2017
Q2
$14.2M Buy
877,857
+104,931
+14% +$1.66M ﹤0.01% 2214
2017
Q1
$13.4M Sell
772,926
-28,687
-4% -$480K ﹤0.01% 2214
2016
Q4
$13.5M Buy
801,613
+141,424
+21% +$2.36M ﹤0.01% 2174
2016
Q3
$11.6M Buy
660,189
+54,390
+9% +$882K ﹤0.01% 2110
2016
Q2
$8.7M Buy
605,799
+11,679
+2% +$146K ﹤0.01% 2302
2016
Q1
$7.3M Buy
594,120
+65,330
+12% +$722K ﹤0.01% 2348
2015
Q4
$6.42M Buy
528,790
+27,180
+5% +$335K ﹤0.01% 2413
2015
Q3
$6.62M Buy
501,610
+7,106
+1% +$107K ﹤0.01% 2385
2015
Q2
$8.11M Buy
494,504
+25,141
+5% +$417K ﹤0.01% 2385
2015
Q1
$8.35M Sell
469,363
-12,456
-3% -$232K ﹤0.01% 2305
2014
Q4
$9.16M Buy
481,819
+31,109
+7% +$527K ﹤0.01% 2258
2014
Q3
$6.18M Sell
450,710
-3,108
-0.7% -$44.4K ﹤0.01% 2437
2014
Q2
$7.41M Sell
453,818
-5,054
-1% -$73.2K ﹤0.01% 2380
2014
Q1
$7.22M Buy
458,872
+10,975
+2% +$179K ﹤0.01% 2370
2013
Q4
$7.7M Sell
447,897
-10,286
-2% -$158K ﹤0.01% 2327
2013
Q3
$6.05M Sell
458,183
-9,666
-2% -$114K ﹤0.01% 2420
2013
Q2
$5.27M Buy
+467,849
New +$4.98M ﹤0.01% 2432

Other funds holding ANGO

State Street's ANGO Position: Q1 2026 in Review

State Street increased its AngioDynamics (ANGO) stake by 4.8% in Q1 2026, buying an estimated $662K and bringing the position to 1,333,858 shares worth $15.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2386.

State Street first reported a position in ANGO in Q2 2013 and has held it in 52 quarters since. The position peaked at $51.1M in Q2 2021. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • State Street held 1,333,858 shares of AngioDynamics worth $15.2M as of Q1 2026.
  • State Street bought 61,123 AngioDynamics shares in Q1 2026, an estimated $662K.
  • AngioDynamics made up ﹤0.01% of State Street's portfolio in Q1 2026, its #2386 holding.
  • State Street first reported a position in AngioDynamics in Q2 2013 and has held it in 52 quarters since.
  • State Street's AngioDynamics position peaked at $51.1M in Q2 2021.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.